316 related articles for article (PubMed ID: 34959448)
1. The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers.
Chen TC; da Fonseca CO; Levin D; Schönthal AH
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959448
[TBL] [Abstract][Full Text] [Related]
2. Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.
Chen TC; Fonseca CO; Schönthal AH
Am J Cancer Res; 2015; 5(5):1580-93. PubMed ID: 26175929
[TBL] [Abstract][Full Text] [Related]
3. Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case.
Schönthal AH; Swenson S; Bonney PA; Wagle N; Simmon VF; Mathew AJ; Hurth KM; Chen TC
J Neurosurg Case Lessons; 2022 Aug; 4(8):. PubMed ID: 36088606
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development.
Chen TC; da Fonseca CO; Schönthal AH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563210
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the Antiproliferative Activity of Perillyl Alcohol against Glioblastoma Cell Lines through Synergistic Formulation with Natural Oils.
Alharbi WS; Alshehri AA; Ahmed TA; Md S; Almehmady AM; Alshabibi MA; Altamimi RM; El-Say KM
Curr Pharm Des; 2024 Mar; ():. PubMed ID: 38532602
[TBL] [Abstract][Full Text] [Related]
6. NEO100 enables brain delivery of blood‒brain barrier impermeable therapeutics.
Wang W; Marín-Ramos NI; He H; Zeng S; Cho HY; Swenson SD; Zheng L; Epstein AL; Schönthal AH; Hofman FM; Chen L; Chen TC
Neuro Oncol; 2021 Jan; 23(1):63-75. PubMed ID: 32877532
[TBL] [Abstract][Full Text] [Related]
7. Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers.
Peczek SH; Tartari APS; Zittlau IC; Diedrich C; Machado CS; Mainardes RM
Pharmaceuticals (Basel); 2023 Jul; 16(8):. PubMed ID: 37630970
[TBL] [Abstract][Full Text] [Related]
8. Perillyl alcohol: Dynamic interactions with the lipid bilayer and implications for long-term inhalational chemotherapy for gliomas.
da Fonseca CO; Khandelia H; Salazar MD; Schönthal AH; Meireles OC; Quirico-Santos T
Surg Neurol Int; 2016; 7():1. PubMed ID: 26862440
[TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats.
Nehra G; Andrews S; Rettig J; Gould MN; Haag JD; Howard SP; Thorne RG
Sci Rep; 2021 Mar; 11(1):6351. PubMed ID: 33737566
[TBL] [Abstract][Full Text] [Related]
10. Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models.
Wang W; Swenson S; Cho HY; Hofman FM; Schönthal AH; Chen TC
J Neurosurg; 2019 Mar; 132(3):959-967. PubMed ID: 30875688
[TBL] [Abstract][Full Text] [Related]
11. Perillyl alcohol for the treatment of temozolomide-resistant gliomas.
Cho HY; Wang W; Jhaveri N; Torres S; Tseng J; Leong MN; Lee DJ; Goldkorn A; Xu T; Petasis NA; Louie SG; Schönthal AH; Hofman FM; Chen TC
Mol Cancer Ther; 2012 Nov; 11(11):2462-72. PubMed ID: 22933703
[TBL] [Abstract][Full Text] [Related]
12. Development of a perillyl alcohol topical cream formulation.
Gupta A; Myrdal PB
Int J Pharm; 2004 Jan; 269(2):373-83. PubMed ID: 14706249
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
da Fonseca CO; Schwartsmann G; Fischer J; Nagel J; Futuro D; Quirico-Santos T; Gattass CR
Surg Neurol; 2008 Sep; 70(3):259-66; discussion 266-7. PubMed ID: 18295834
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous measurement of perillyl alcohol and its metabolite perillic acid in plasma and lung after inhalational administration in Wistar rats.
de Lima DC; Rodrigues SV; Boaventura GT; Cho HY; Chen TC; Schönthal AH; Da Fonseca CO
Drug Test Anal; 2020 Feb; 12(2):268-279. PubMed ID: 31800149
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol.
da Fonseca CO; Landeiro JA; Clark SS; Quirico-Santos T; da Costa Carvalho Mda G; Gattass CR
Surg Neurol; 2006; 65 Suppl 1():S1:2-1:8; discussion S1:8-1:9. PubMed ID: 16427438
[TBL] [Abstract][Full Text] [Related]
16. Perillyl Alcohol (Monoterpene Alcohol), Limonene.
Shojaei S; Kiumarsi A; Moghadam AR; Alizadeh J; Marzban H; Ghavami S
Enzymes; 2014; 36():7-32. PubMed ID: 27102697
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma.
Schönthal AH; Peereboom DM; Wagle N; Lai R; Mathew AJ; Hurth KM; Simmon VF; Howard SP; Taylor LP; Chow F; da Fonseca CO; Chen TC
Neurooncol Adv; 2021; 3(1):vdab005. PubMed ID: 33604574
[TBL] [Abstract][Full Text] [Related]
18. Polycyclic aromatic hydrocarbon-induced CYP1B1 activity is suppressed by perillyl alcohol in MCF-7 cells.
Chan NL; Wang H; Wang Y; Leung HY; Leung LK
Toxicol Appl Pharmacol; 2006 Jun; 213(2):98-104. PubMed ID: 16307765
[TBL] [Abstract][Full Text] [Related]
19. Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria.
Marin AA; Murillo O; Sussmann RA; Ortolan LS; Battagello DS; de Castro Quirino T; Bittencourt JC; Epiphanio S; Katzin AM; Carvalho LJM
Antimicrob Agents Chemother; 2023 May; 65(5):. PubMed ID: 33649109
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma.
Santos JG; Da Cruz WMS; Schönthal AH; Salazar MD; Fontes CAP; Quirico-Santos T; Da Fonseca CO
Oncol Lett; 2018 Jan; 15(1):1263-1270. PubMed ID: 29391903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
